We believe that forming a team between your doctor, yourself, and researchers creating promising options from around the world, could extend your life. Our non-profit aims to educate by curating resources, collecting funds to provide freedom-of-pursuit awards to researchers, and ultimately expanding possibilities to you. Be involved and begin the I-Team Process in three steps.
Begin Your Journey: Step 1 Register
Complete a simple online form to register with us and Join the I-Team network. Receive a welcome email with links to the current standard of care information and clinical trials from us about your specific cancer.
- Join Your Investigative-Team (I-Team) Network as a Patient, Doctor, Researcher, Volunteer, Advocate, and/or Employee
- Become a Recipient of our Options Newsletter
Begin Your Journey: Step 2 Donate
Help ICARE build the I-Team network in your cancer type that harnesses the global intellect (including ideas, therapies, and technologies) and delivers it locally to you and your doctor.
- Donate Funds to Expand Cancer Options
- Donate Therapeutic Knowledge to the Network
- Donate Tumor Tissues Through Your I-Team Network
- Donate Your Time
Begin Your Journey: Step 3 Participate
Actively participate in your I-Team’s regular online research meetings. Collaborate with physicians and scientists around the world to discover more and better therapeutic options with the ultimate goal of improving each patient’s chances of survival. Link to information to facilitate the inclusion of your living tumor tissue into the I-Team process.
- Digital and/or In-Person Meetings with Physicians and Scientists
- Discover Even More Therapeutic Options
- Identify Targeted Treatments with Your Living Tumor Tissue
We are sorry about your diagnosis but we are pleased that you have found the International Cancer Alliance for Research and Education (ICARE) — a 501(3)(c) tax exempt public charity since 1985. In 2010, ICARE.org began to focus its programs on building and funding local and international medical academic research teams (I-TEAMS) that can support decisions of individual patients and their doctors — rather than on just providing research information to the general public.
Immunotherapy for Glioblastoma Well Tolerated; Survival Gains Observed Friday, April 14, 2017 Small, phase one trial of a dendritic cell vaccine supports further study in...
Dr. Ronald Levy’s Stanford Laboratory recently published the success of a new immunotherapy approach to treatment of advanced cancers. Here is the abstract from the...